eLaws | eCases | United States Code | Federal Courts |

Amendment to the Current Good Manufacturing Practice Regulations for Finished Pharmaceuticals

Document ID: FDA-2007-0614-0002
Document Type: Rule
Agency: Food And Drug Administration
Topics: No Topics associated with this document
Federal Register Number: E7-23294
CFR Citation: 21 CFR 210,211
View Document:

Details Information

Document Subtype:	NFR-Notice of Final Rule
Received Date:	December 04 2007, at 07:11 AM Eastern Standard Time
Page Count:	7
Comment Start Date:	December 4 2007, at 12:00 AM Eastern Standard Time
Comment Due Date:	February 19 2008, at 11:59 PM Eastern Standard Time

Comments

View All

Total: 21

sanofi-aventis - Comment
Posted: 02/10/2008 ID: FDA-2007-0614-0006

Comment Period Closed
Feb 19,2008 11:59 PM ET

Abbott Laboratories - Comment
Posted: 02/10/2008 ID: FDA-2007-0614-0007

Comment Period Closed
Feb 19,2008 11:59 PM ET

Compressed Gas Association/GAWDA - Comment
Posted: 02/20/2008 ID: FDA-2007-0614-0010

Comment Period Closed
Feb 19,2008 11:59 PM ET

Genzyme Corporation - Comment
Posted: 02/20/2008 ID: FDA-2007-0614-0012

Comment Period Closed
Feb 19,2008 11:59 PM ET

Compressed Gas Association/GAWDA - Comment
Posted: 02/20/2008 ID: FDA-2007-0614-0013

Comment Period Closed
Feb 19,2008 11:59 PM ET

Related Documents

Total: 4

Amendments to the Current Good Manufacturing Practice Regulations for Finished Pharmaceuticals; Final Rule; Correction

Amendments to the Current Good Manufacturing Practice Regulations for Finished Pharmaceuticals

Amendment to the Current Good Manufacturing Practice Regulations for Finished Pharmaceuticals; Withdrawal [Re: FDA-2007-N-0379]

Amendment to the Current Good Manufacturing Practice Regulations for Finished Pharmaceuticals; Companion Document to the Direct Final Rule